Epilepsy in children with infantile thiamine deficiency

A Fattal-Valevski1, A Bloch-Mimouni, S Kivity

  • 1Pediatric Neurology Unit, Dana Children's Hospital, Sourasky Medical Center, 6 Weitzman St., Tel Aviv, 64239, Israel. afatal@post.tau.ac.il

Neurology
|July 3, 2009
PubMed

Insights

Severe infantile thiamine deficiency from soy formula caused epilepsy in 7 children. Follow-up shows persistent seizures, developmental delays, and brainstem dysfunction, indicating long-term neurological impact.

Area of Science:

  • Pediatric Neurology
  • Nutritional Neuroscience
  • Developmental Pediatrics

Background:

  • Infantile epilepsy is a significant concern with various etiologies.
  • Thiamine (vitamin B1) is crucial for neurological development.
  • Defective infant formulas can pose serious health risks.

Purpose of the Study:

  • To present follow-up findings in children with epilepsy linked to infantile thiamine deficiency.
  • To describe the long-term neurological outcomes after exposure to a defective soy-based formula.

Main Methods:

  • Retrospective review of medical records for 7 children aged 5-6 years.
  • Analysis of clinical data, electroencephalogram (EEG) tracings, and neuroimaging.
  • Assessment of seizure types, treatment response, and developmental status 5 years post-deficiency.

Main Results:

  • All 7 children experienced seizures (tonic, myoclonic, focal) during infancy.
  • Recurrent seizures, including myoclonic and complex partial, developed in all children.
  • EEG abnormalities evolved, with 3 cases showing hypsarrhythmia; seizures were often refractory to antiepileptic drugs.
  • All children exhibit mental retardation, motor disabilities, and brainstem dysfunction symptoms.

Conclusions:

  • Severe infantile thiamine deficiency is a potential cause of epilepsy.
  • This deficiency can lead to persistent, severe neurological impairment, including epilepsy and developmental deficits.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...